FilingsTodayWest Pharmaceutical Services
At a glance
West Pharmaceutical Services reported 2025 revenue of $3.07B, up 6.3% from $2.89B in 2024. Over 4 years since 2021 ($2.83B), that is growth of about 2.1% a year. Operating margin was 19%, down from 26.6% in 2021. 2025 was the highest revenue year in this period.
In the last 12 months 2 insiders reported 0 open-market purchases and 4 sales ($6.6M). 1 of the sales were made under pre-arranged 10b5-1 plans. The largest was a sale of $2.8M by Sr. VP & Chief HR Officer Annette F Favorite on Sep 10, 2026.
West Pharmaceutical Services filed 11 current reports (Form 8-K) in the last 12 months, most often for results of operations (4), material agreement (2), officer or director change (2) and cybersecurity incident (2). The latest officer or director change was reported on Jun 1, 2026. It reported a material agreement or a completed acquisition or disposal 2 times.
Annual results
| Year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net income | $661.8M | $585.9M | $593.4M | $492.7M | $493.7M |
| Diluted EPS | $8.67 | $7.73 | $7.88 | $6.69 | $6.79 |
| Dividend per share | $0.70 | $0.74 | $0.78 | $0.82 | $0.86 |
Fiscal year ends Dec 31 · incorporated in PA
Current reports (8-K, last 12 months)
Insider open-market trades (last 12 months)
Source: SEC EDGAR. How figures are combined